Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease LR Marks, BA Davidson, PR Knight, AP Hakansson MBio 4 (4), 10.1128/mbio. 00438-13, 2013 | 249 | 2013 |
Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease Y Chao, LR Marks, MM Pettigrew, AP Hakansson Frontiers in cellular and infection microbiology 4, 194, 2015 | 238 | 2015 |
High levels of genetic recombination during nasopharyngeal carriage and biofilm formation in Streptococcus pneumoniae LR Marks, RM Reddinger, AP Hakansson MBio 3 (5), 10.1128/mbio. 00200-12, 2012 | 206* | 2012 |
Pneumococcal Interactions with Epithelial Cells Are Crucial for Optimal Biofilm Formation and Colonization In Vitro and In Vivo LR Marks, GI Parameswaran, AP Hakansson Infection and immunity 80 (8), 2744-2760, 2012 | 204 | 2012 |
Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder LR Marks, S Munigala, DK Warren, SY Liang, ES Schwarz, MJ Durkin Clinical Infectious Diseases 68 (11), 1935-1937, 2019 | 147 | 2019 |
Growth signaling promotes chronological aging in budding yeast by inducing superoxide anions that inhibit quiescence M Weinberger, A Mesquita, T Carroll, L Marks, H Yang, Z Zhang, ... Aging (Albany NY) 2 (10), 709, 2010 | 135 | 2010 |
Streptococcus pyogenes Biofilm Growth In Vitro and In Vivo and Its Role in Colonization, Virulence, and Genetic Exchange LR Marks, L Mashburn-Warren, MJ Federle, AP Hakansson The Journal of infectious diseases 210 (1), 25-34, 2014 | 128 | 2014 |
Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection MM Pettigrew, LR Marks, Y Kong, JF Gent, H Roche-Hakansson, ... Infection and immunity 82 (11), 4607-4619, 2014 | 117 | 2014 |
Biofilm formation enhances fomite survival of Streptococcus pneumoniae and Streptococcus pyogenes LR Marks, RM Reddinger, AP Hakansson Infection and immunity 82 (3), 1141-1146, 2014 | 112 | 2014 |
The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents LR Marks, EA Clementi, AP Hakansson Public Library of Science 7 (8), e43514, 2012 | 76 | 2012 |
Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET LR Marks, EA Clementi, AP Hakansson PloS one 8 (5), e63158, 2013 | 71 | 2013 |
Monitoring changes in membrane polarity, membrane integrity, and intracellular ion concentrations in Streptococcus pneumoniae using fluorescent dyes EA Clementi, LR Marks, H Roche-Håkansson, AP Håkansson JoVE (Journal of Visualized Experiments), e51008, 2014 | 54 | 2014 |
Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections LR Marks, SY Liang, D Muthulingam, ES Schwarz, DB Liss, S Munigala, ... Clinical Infectious Diseases 71 (10), e650-e656, 2020 | 49 | 2020 |
Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association LM Baddour, MB Weimer, AG Wurcel, DB McElhinney, LR Marks, ... Circulation 146 (14), e187-e201, 2022 | 43 | 2022 |
A novel initiation mechanism of death in Streptococcus pneumoniae induced by the human milk protein-lipid complex HAMLET and activated during physiological death EA Clementi, LR Marks, ME Duffey, AP Hakansson Journal of Biological Chemistry 287 (32), 27168-27182, 2012 | 38 | 2012 |
Medications for opioid use disorder associated with less against medical advice discharge among persons who inject drugs hospitalized with an invasive infection NS Nolan, LR Marks, SY Liang, MJ Durkin Journal of addiction medicine 15 (2), 155-158, 2021 | 30 | 2021 |
Use of ICD-10 codes for identification of injection drug use–associated infective endocarditis is nonspecific and obscures critical findings on impact of medications for opioid … LR Marks, NS Nolan, L Jiang, D Muthulingam, SY Liang, MJ Durkin Open forum infectious diseases 7 (10), ofaa414, 2020 | 29 | 2020 |
Infectious complications of injection drug use LR Marks, NS Nolan, SY Liang, MJ Durkin, MB Weimer Medical Clinics 106 (1), 187-200, 2022 | 28 | 2022 |
Barriers to care experienced by patients who inject drugs during the COVID-19 pandemic: a qualitative analysis E Gleason, NS Nolan, LR Marks, T Habrock, SY Liang, MJ Durkin Journal of addiction medicine 16 (2), e133-e136, 2022 | 26 | 2022 |
A comparison of medication for opioid use disorder treatment strategies for persons who inject drugs with invasive bacterial and fungal infections LR Marks, S Munigala, DK Warren, DB Liss, SY Liang, ES Schwarz, ... The Journal of Infectious Diseases 222 (Supplement_5), S513-S520, 2020 | 26 | 2020 |